FDA Section 4 \u2022 who must NOT take this

Desloratadine - Contraindications

These conditions, allergies, and situations mean Desloratadine should NOT be used. From the US FDA-approved drug label Section 4.

4 CONTRAINDICATIONS CLARINEX-D 12 HOUR Extended Release Tablets are contraindicated in: Patients with hypersensitivity to any of its ingredients, or to loratadine [see Warnings and Precautions and Adverse Reactions ] Patients with narrow-angle glaucoma Patients with urinary retention Patients receiving monoamine oxidase (MAO) inhibitor therapy or within fourteen days of stopping such treatment [see Drug Interactions ] Patients with severe hypertension or severe coronary artery disease Hypersensitivity Narrow-Angle Glaucoma Urinary Retention Patients Receiving MAO Inhibitors or within 14 days of stopping such treatment Severe hypertension or severe coronary artery disease.

Does any of this apply to YOU?

Ask Health AI \u2192